Zurcher Kantonalbank Zurich Cantonalbank Sells 276 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Zurcher Kantonalbank Zurich Cantonalbank trimmed its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 23,597 shares of the exchange traded fund’s stock after selling 276 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in SPDR S&P Biotech ETF were worth $2,124,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently added to or reduced their stakes in the company. Golden State Wealth Management LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter worth approximately $29,000. Kohmann Bosshard Financial Services LLC bought a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $29,000. Avior Wealth Management LLC increased its position in shares of SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after buying an additional 307 shares in the last quarter. Tidemark LLC increased its position in shares of SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after buying an additional 199 shares in the last quarter. Finally, Bank of Jackson Hole Trust bought a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter valued at $43,000.

SPDR S&P Biotech ETF Trading Up 1.3 %

Shares of NYSEARCA XBI opened at $87.13 on Monday. The firm has a market cap of $5.65 billion, a PE ratio of 11.47 and a beta of 0.99. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47. The company has a fifty day moving average price of $90.06 and a 200 day moving average price of $94.78.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.